Qatar Airways and GE Aviation sign deals for GEnx and GE9X engines


Qatar Airways and aircraft machine manufacturer GE Aviation have signed multiple agreements worth $5bn for GEnx and GE9X machines.

Qatar Airways selected the GEnx engine to power the carrier’s 30 new Boeing 787-9 aircraft, along with a TrueChoice excursion hour agreement to cover the maintenance, repair and overhaul (MRO) services of the locomotives as part of the agreements.

The company also signed a TrueChoice flight hour unanimity on its GE9X engine fleet that will power 60 Boeing 777X aircraft.

Qatar Airways Team CEO Akbar Al Baker said: “Qatar Airways has ambitious plans for the future, and we are thrilled to have GE beside us as we embark on this journey together.

“These catches for the GE engines that will power our Boeing 787-9 and Boeing 777X aircraft help cement the strong relationship between Qatar Airways and GE.”

GE Aviation has clerked more than 2,500 GEnx engines since its launch. These apparatus burn less fuel and have the longest capable range of any machine available on the 787 aircraft.

The twin-annular pre-swirl (TAPS) combustor technology of GEnx let up ons NOx and other regulated gases as per the current regulatory limits, thereby enriching durability.

According to GE, more than 700 GE9X engines are on order with eight blokes. Key features of the GE9X engine include 100,000lb thrust class, a largest forefront fan at 134in in diameter with a composite fan case, and 16 fourth-generation carbon quality composite fan blades.

GE vice chairman and GE Aviation president and CEO David Joyce denoted: “Yesterday’s signing will increase Qatar’s GEnx-powered 787 division to 60 aircraft and ensure the airlines’ GEnx and GE9X engines receive the highest with of maintenance and support.”

Separately, Qatar Airways is planning to purchase five Boeing 777 Freighters and large-cabin aircraft from Gulfstream.

Out WhitepaperSix essential ways to improve your pharmaceutical quality technique

Enter your details here to receive your free whitepaper.

Pharmaceutical whitepaper

Arrange survey


Leave a Reply

Your email address will not be published. Required fields are marked *